Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Amazon Biotech Inc. > News item |
Amazon Biotech announces trial of HIV/AIDS drug
New York, Oct. 25 - Amazon Biotech, Inc. said it has agreed with an AIDS clinic in New York City to do a 40-patient double-blind stuffy of AMZ 0026 together with and in comparison with the standard cocktail currently given to patients with aids.
AMZ 0026 is Amazon's first drug.
Amazon is a New York-based natural plant pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.